Reported figures and Equlion model projections for the next 5 years.
ROE
-11 pt
Company
ROA
-5.8 pt
Company
Gross Margin
-12.4 pt
Company
Net Margin
-8.2 pt
Company
Total Assets
+53%
Company
Sector average (own scale)
Net Income
-406.4%
Company
Valuation
+190%
Company
Sector average (own scale)
Stock Price
+190%
Company
Sector average
Amounts in EUR (thousands); stock price per share. Values that are missing or fail Equlion's automated data-quality checks are shown as “-”. Stock price and valuation carry no data date: they are the Equlion model's estimate for 2025. Projections are model estimates, not investment advice.
Want the full financial forecast report for EUROBIO-SCIENTIFIC? It covers the balance sheet, income statement, cash flow and Equlion model projections.